Compare WY & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WY | STE |
|---|---|---|
| Founded | 1900 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | WY | STE |
|---|---|---|
| Price | $23.33 | $254.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $28.38 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 6.8M | 619.9K |
| Earning Date | 01-29-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.59% | 1.00% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | 0.46 | ★ 6.97 |
| Revenue | ★ $7,072,000,000.00 | $5,702,415,000.00 |
| Revenue This Year | $0.08 | $9.61 |
| Revenue Next Year | $2.86 | $6.23 |
| P/E Ratio | $51.20 | ★ $36.12 |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $21.16 | $200.98 |
| 52 Week High | $31.66 | $268.60 |
| Indicator | WY | STE |
|---|---|---|
| Relative Strength Index (RSI) | 60.97 | 45.89 |
| Support Level | $21.94 | $249.92 |
| Resistance Level | $23.76 | $261.45 |
| Average True Range (ATR) | 0.55 | 4.93 |
| MACD | 0.25 | -1.76 |
| Stochastic Oscillator | 83.31 | 22.75 |
Weyerhaeuser ranks among the world's largest forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.